On April 9, 2026, Oxford BioTherapeutics announced a multi-year collaboration with Bristol Myers Squibb focused on the discovery and development of T-cell engager therapies for solid tumors. 1 ...

This figure illustrates three key applications of AI in antimicrobial drug development: (1) target identification and validation, including novel target discovery, affinity prediction, multi-target ...

The workflow of metabolomics can be divided into four parts: (1) sample collection and preparation; (2) metabolic profiling; (3) data processing and analysis; and (4) pathway analysis (created by ...